The lead story of the fire at the Notre-Dame cathedral of Paris.

Blood lead levels Paris Public health

Journal

Environmental pollution (Barking, Essex : 1987)
ISSN: 1873-6424
Titre abrégé: Environ Pollut
Pays: England
ID NLM: 8804476

Informations de publication

Date de publication:
15 Jan 2021
Historique:
received: 21 08 2020
revised: 30 10 2020
accepted: 19 11 2020
pubmed: 15 12 2020
medline: 7 1 2021
entrez: 14 12 2020
Statut: ppublish

Résumé

On 15th April 2019, Parisians watched in shock as Notre-Dame de Paris, the iconic cathedral that has towered over their city for almost 900 years, was engulfed in flames. Although flames destroyed the spire and considerably weakened the structure, no human lives were lost. However, as some amounts of lead volatilized and deposited in the surrounding areas, fears of potential intoxication began to rise. We investigated the impact of this fire on the blood lead levels of adults in Paris according to the distance between the cathedral and where they live or work. The geometric mean of blood lead levels of the study population was 1.49μg/dl (95% CI [1.38-1.62]) with a prevalence of blood lead levels≥5.0μg/dL of 5.0%. Despite the early legitimate fears of intoxication, the fire that destroyed a significant part of the Notre-Dame cathedral did not increase the blood lead levels of adults living and working in the vicinity.

Identifiants

pubmed: 33316489
pii: S0269-7491(20)36829-9
doi: 10.1016/j.envpol.2020.116140
pii:
doi:

Substances chimiques

Lead 2P299V784P

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

116140

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest We as authors have no conflict of interests for the paper titled: The lead story of the fire at the Notre-Dame cathedral of Paris

Auteurs

Alexandre Vallée (A)

Centre de Diagnostic et de Thérapeutique, Hôpital Universitaire Hôtel-Dieu, AP-HP, Université de Paris, France.

Emmanuel Sorbets (E)

Centre de Diagnostic et de Thérapeutique, Hôpital Universitaire Hôtel-Dieu, AP-HP, Université de Paris, France.

Hélène Lelong (H)

Centre de Diagnostic et de Thérapeutique, Hôpital Universitaire Hôtel-Dieu, AP-HP, Université de Paris, France.

Jérôme Langrand (J)

Centre Antipoison de Paris, Fédération de Toxicologie, Inserm UMR-S 1144, Hôpital Lariboisière-Fernand Widal, AP-HP, Paris, France.

Jacques Blacher (J)

Centre de Diagnostic et de Thérapeutique, Hôpital Universitaire Hôtel-Dieu, AP-HP, Université de Paris, France. Electronic address: jacques.blacher@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH